Higher-Dose Ivermectin for Outpatients With COVID-19, Trends in Cardiovascular Risk Factor Prevalence and Control in US Adults, Review of Chronic Lymphocytic Leukemia, and more
Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 21, 2023 issue.
Source: JAMA: This Week's Audio Commentary - Category: General Medicine Authors: JAMA Network Source Type: podcasts
More News: American Medical Association (AMA) | Cardiology | Cardiovascular | Chronic Leukemia | Chronic Lymphocytic Leukemia | COVID-19 | General Medicine | Heart | Leukemia